A. Olvera

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A Olvera, A. Olvera, Alejandro Olvera
Publication record
33 papers · 509 citations · H-index 15

PAPERS

Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19
20240 citationsauthor #10
Multiple Interventions to Thoracoabdominal Aortic Aneurysm in a Child with Tuberous Sclerosis.
20224 citationsauthor #1
Neotropical Rattlesnake (Crotalus simus) Venom Pharmacokinetics in Lymph and Blood Using an Ovine Model
202021 citationsauthor #7
Functional, proteomic and transcriptomic characterization of the venom from Micrurus browni browni: Identification of the first lethal multimeric neurotoxin in coral snake venom.
202018 citationsauthor #5
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
202020 citationsauthor #6
216P The impact of pregnancy-associated breast cancer (PABC) according to immunohistochemical (IHC) subtype: A matched case-control study
20201 citationsauthor #8
Clinicopathological features and prognosis of pregnancy associated breast cancer at Instituto Nacional de Cancerología of Mexico.
20180 citationsauthor #8
Recombinant-phospholipase A2 production and architecture of inclusion bodies are affected by pH in Escherichia coli.
201712 citationsauthor #2
Production of a recombinant phospholipase A2 in Escherichia coli using resonant acoustic mixing that improves oxygen transfer in shake flasks
201720 citationsauthor #6
An efficient approach to clone and express active Neopladine 2, an anticancer peptide from Tityus discrepans scorpion venom
20164 citationsauthor #3
Influence of pH control in the formation of inclusion bodies during production of recombinant sphingomyelinase-D in Escherichia coli
201452 citationsauthor #3
Corrigendum to “Intraspecific differences in the immunochemical reactivity and neutralization of venom from Argentinean Bothrops (Rhinocerophis) alternatus by specific experimental antivenoms” [Toxicon 85 (2014) 31–45]
20140 citationsauthor #2
216. Experimental, Immunochemical Reactivity and Neutralizing Capacity of Rhinocerophis (Bothrops) alternatus Antivenoms, from Distinct Geographical Sources
20120 citationsauthor #2
165. Molecular Cloning, Expression and Structure-Function Analysis of Neopladine-2, an Antineoplastic Peptide from Tityus discrepans Scorpion Venom
20120 citationsauthor #3
Identification, cDNA cloning and heterologous expression of a hyaluronidase from the tarantula Brachypelma vagans venom.
201223 citationsauthor #2
Cloning, sequencing and expression in the dog of the main amyloid precursor protein isoforms and some of the enzymes related with their processing.
201021 citationsauthor #4
Heterologous expressed toxic and non-toxic peptide variants of toxin CssII are capable to produce neutralizing antibodies against the venom of the scorpion Centruroides suffusus suffusus.
200924 citationsauthor #3
Response to Moolenaar et al.
20071 citationsauthor #5
Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms
200719 citationsauthor #5
Upregulation of IL-6, IL-8, CXCL1, and CXCL2 dominates gene expression in human fibroblast cells exposed to Loxosceles reclusa sphingomyelinase D: insights into spider venom dermonecrosis.
200736 citationsauthor #5
North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens.
200664 citationsauthor #1
From “Snakebites in the new millennium: A state-of-the-art symposium”
20060 citationsauthor #46
Snakebites in the new millennium. Proceedings of a state-of-the-art symposium. October 21-13, 2005. Omaha, Nebraska, USA.
20060 citationsauthor #46
Erratum to “Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles reclusa” [Toxicon 44 (2004) 507–514]
20051 citationsauthor #2
Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles reclusa.
200468 citationsauthor #2
Short communication Characterization of the Ehrab8 gene, a marker of the late stages of the secretory pathway of Entamoeba histolytica
200123 citationsauthor #4
Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers
200142 citationsauthor #2
Molecular genetics of the secretory pathway in Entamoeba histolytica: an overview.
20003 citationsauthor #4
Inhibition of neomycin phosphorotransferase expression in Entamoeba histolytica with antisense peptide nucleic acid (PNA) oligomers.
20007 citationsauthor #2
Stable transfection of E. histolytica trophozoites by lipofection
19970 citationsauthor #1
Stable transfection of Entamoeba histolytica trophozoites by lipofection.
199725 citationsauthor #1
[Impact of new methodologies in the study of parasites].
19960 citationsauthor #5
Design of a Low-Cost Spirometer to Detect COPD and Asthma for Remote Health Monitoring
year unknown0 citationsauthor #1

TIMELINE

1996 0 citations

1997 25 citations

2000 10 citations

2001 65 citations

2004 68 citations

2005 1 citations

2006 64 citations

2007 56 citations

2009 24 citations

2010 21 citations

2012 23 citations

2014 52 citations

2016 4 citations

2017 32 citations

2018 0 citations

2020 60 citations

2022 4 citations

2024 0 citations

Unknown 0 citations

A. Olvera

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT